Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Zeteletinib |
| Trade Name | |
| Synonyms | DS5010|DS 5010|BOS172738|BOS-172738|BOS 172738|DS-5010 |
| Drug Descriptions |
Zeteletinib (DS-5010) is a multi-kinase inhibitor that inhibits RET and KDR (VEGFR2), which may lead to inhibition of tumor cell growth (Cancer Res 2019;79(13 Suppl):Abstract nr 2199). |
| DrugClasses | RET Inhibitor 53 VEGFR2 Inhibitor 37 |
| CAS Registry Number | 2216753-97-6 |
| NCIT ID | C158093 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Zeteletinib | Zeteletinib | 4 | 1 |